{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T20:51:02Z","timestamp":1761252662702},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2010,10,13]],"date-time":"2010-10-13T00:00:00Z","timestamp":1286928000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0013328","type":"journal-article","created":{"date-parts":[[2010,10,13]],"date-time":"2010-10-13T22:56:28Z","timestamp":1287010588000},"page":"e13328","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Towards a Rational Screening Strategy for Albuminuria: Results from the Unreferred Renal Insufficiency Trial"],"prefix":"10.1371","volume":"5","author":[{"given":"Arjan","family":"van der Tol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wim","family":"Van Biesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"Verbeke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"De Groote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frans","family":"Vermeiren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Eeckhaut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Vanholder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2010,10,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1093\/ndt\/gfp519","article-title":"An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006.","volume":"24","author":"A Kramer","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"ref2"},{"key":"ref3"},{"key":"ref4"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1097\/00004872-199816090-00014","article-title":"Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension.","volume":"16","author":"R Bigazzi","year":"1998","journal-title":"Journal of Hypertension"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s001250051151","article-title":"Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas.","volume":"42","author":"CE Mogensen","year":"1999","journal-title":"Diabetologia"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","article-title":"Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2215\/CJN.01381005","article-title":"Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study.","volume":"1","author":"WF Keane","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1681\/ASN.2008060655","article-title":"Screening for Albuminuria Identifies Individuals at Increased Renal Risk.","volume":"20","author":"M van der Velde","year":"2009","journal-title":"Journal of the American Society of Nephrology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/bmj.39001.657755.BE","article-title":"Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey.","volume":"333","author":"SI Hallan","year":"2006","journal-title":"British Medical Journal"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1681\/ASN.2009020147","article-title":"Are we ready to screen the general population for microalbuminuria?","volume":"20","author":"L Fried","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5414\/CNP59241","article-title":"Clinical relevance of microalbuminuria screening in self-reported non-diabetic\/non-hypertensive persons identified in a large health screening - The Nord-Trondelag Health Study (HUNT), Norway.","volume":"59","author":"S Romundstad","year":"2003","journal-title":"Clinical Nephrology"},{"key":"ref13","first-page":"281","article-title":"[Principles and practice of mass screening for disease].","volume":"65","author":"JM Wilson","year":"1968","journal-title":"Bol Oficina Sanit Panam"},{"key":"ref14"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1681\/ASN.V76930","article-title":"Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin\/creatinine ratio.","volume":"7","author":"JH Warram","year":"1996","journal-title":"Journal of the American Society of Nephrology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.","volume":"145","author":"AS Levey","year":"2006","journal-title":"Ann Intern Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.2337\/diacare.26.11.3160","article-title":"Follow-up report on the diagnosis of diabetes mellitus.","volume":"26","author":"S Genuth","year":"2003","journal-title":"Diabetes Care"},{"key":"ref18","first-page":"147","article-title":"Screening for chronic kidney disease: which strategy?","volume":"23","author":"SI Hallan","year":"2010","journal-title":"J Nephrol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/1471-2458-9-381","article-title":"The usefulness of a free self-test for screening albuminuria in the general population: a cross-sectional survey.","volume":"9","author":"MM Nielen","year":"2009","journal-title":"BMC Public Health"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2796.2006.01679.x","article-title":"Very low level of microalbuminuria is associated with increased risk of death in subjects with cardiovascular or cerebrovascular diseases.","volume":"260","author":"KP Klausen","year":"2006","journal-title":"Journal of Internal Medicine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.CIR.0000133312.96477.48","article-title":"Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes.","volume":"110","author":"K Klausen","year":"2004","journal-title":"Circulation"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.CIR.0000031732.78052.81","article-title":"Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population.","volume":"106","author":"HL Hillege","year":"2002","journal-title":"Circulation"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1046\/j.1365-2796.2001.00833.x","article-title":"Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity.","volume":"249","author":"HL Hillege","year":"2001","journal-title":"Journal of Internal Medicine"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/CIRCULATIONAHA.105.538132","article-title":"Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study.","volume":"112","author":"J Arnlov","year":"2005","journal-title":"Circulation"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.ijo.0800388","article-title":"Associations between body morphology and microalbuminuria in healthy middle-aged European, Maori and Pacific Island New Zealanders.","volume":"21","author":"PA Metcalf","year":"1997","journal-title":"Int J Obes Relat Metab Disord"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1365-2796.2007.01839.x","article-title":"The association between metabolic syndrome, microalbuminuria and impaired renal function in the general population: impact on cardiovascular disease and mortality.","volume":"262","author":"KP Klausen","year":"2007","journal-title":"Journal of Internal Medicine"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"E261","DOI":"10.25011\/cim.v32i4.6616","article-title":"Prevalence and duration of exercise induced albuminuria in healthy people.","volume":"32","author":"KL Heathcote","year":"2009","journal-title":"Clin Invest Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1159\/000292500","article-title":"Should Microalbuminuria Ever Be Considered as a Renal Endpoint in Any Clinical Trial?","volume":"31","author":"MR Weir","year":"2010","journal-title":"American Journal of Nephrology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0140-6736(03)14739-3","article-title":"Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.","volume":"362","author":"F Turnbull","year":"2003","journal-title":"Lancet"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1681\/ASN.V122218","article-title":"Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study.","volume":"12","author":"LM Ruilope","year":"2001","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1001\/jama.1992.03490210067037","article-title":"Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group.","volume":"268","author":"WG Walker","year":"1992","journal-title":"JAMA: the journal of the American Medical Association"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes.","volume":"359","author":"RR Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/HJH.0b013e3282f05c8a","article-title":"Association of heart rate with microalbuminuria in cardiovascular risk patients: data from I-SEARCH.","volume":"26","author":"M Bohm","year":"2008","journal-title":"Journal of Hypertension"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10157-009-0193-3","article-title":"Heart rate as a risk factor for developing chronic kidney disease: longitudinal analysis of a screened cohort.","volume":"13","author":"T Inoue","year":"2009","journal-title":"Clin Exp Nephrol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/0895-7061(96)87747-8","article-title":"Enhanced sympathetic nervous system activity. The linchpin between insulin resistance, hyperinsulinemia, and heart rate.","volume":"9","author":"FS Facchini","year":"1996","journal-title":"Am J Hypertens"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/0002-8703(93)90128-V","article-title":"Influence of heart rate on mortality among persons with hypertension: the Framingham Study.","volume":"125","author":"MW Gillman","year":"1993","journal-title":"Am Heart J"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pcad.2009.06.001","article-title":"Elevated heart rate: a \u201cnew\u201d cardiovascular risk factor?","volume":"52","author":"P Palatini","year":"2009","journal-title":"Progress in cardiovascular diseases"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.amjcard.2008.08.071","article-title":"Relation of heart rate at rest and long-term (>20 years) death rate in initially healthy middle-aged men.","volume":"103","author":"X Jouven","year":"2009","journal-title":"The American journal of cardiology"},{"key":"ref39","first-page":"54","article-title":"Smoking: a factor promoting onset and progression of diabetic nephropathy.","volume":"26","author":"E Ritz","year":"2000","journal-title":"Diabetes Metab"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1001\/jama.292.18.2227","article-title":"Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.","volume":"292","author":"GL Bakris","year":"2004","journal-title":"JAMA"},{"key":"ref41","first-page":"s1","article-title":"K\/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification.","volume":"39","year":"2002","journal-title":"American Journal of Kidney Diseases"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/archinte.1990.00390140091020","article-title":"Identifying patients with incipient diabetic nephropathy. Should 24-hour urine collections be used?","volume":"150","author":"CD Stehouwer","year":"1990","journal-title":"Arch Intern Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1681\/ASN.2008030292","article-title":"First morning voids are more reliable than spot urine samples to assess microalbuminuria.","volume":"20","author":"EC Witte","year":"2009","journal-title":"J Am Soc Nephrol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0013328","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T20:36:10Z","timestamp":1636662970000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0013328"}},"subtitle":[],"editor":[{"given":"Joseph S.","family":"Ross","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2010,10,13]]},"references-count":43,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2010,10,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0013328","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,13]]}}}